AR019331A2 - Composicion farmaceutica que contiene un sensibilizador a insulina y un secretagogo de insulina. - Google Patents

Composicion farmaceutica que contiene un sensibilizador a insulina y un secretagogo de insulina.

Info

Publication number
AR019331A2
AR019331A2 ARP990102953A ARP990102953A AR019331A2 AR 019331 A2 AR019331 A2 AR 019331A2 AR P990102953 A ARP990102953 A AR P990102953A AR P990102953 A ARP990102953 A AR P990102953A AR 019331 A2 AR019331 A2 AR 019331A2
Authority
AR
Argentina
Prior art keywords
insulin
pharmaceutical composition
composition containing
secretagog
sensitizer
Prior art date
Application number
ARP990102953A
Other languages
English (en)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10816177&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR019331(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of AR019331A2 publication Critical patent/AR019331A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Una composicion farmacéutica que comprende un sensibilizador a insulina, una cantidad sub-máxima de un secretagogo de insulina, un vehículofarmacéuticamente aceptable.
ARP990102953A 1997-07-18 1999-06-18 Composicion farmaceutica que contiene un sensibilizador a insulina y un secretagogo de insulina. AR019331A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9715306A GB9715306D0 (en) 1997-07-18 1997-07-18 Novel method of treatment

Publications (1)

Publication Number Publication Date
AR019331A2 true AR019331A2 (es) 2002-02-13

Family

ID=10816177

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP980103516A AR016768A1 (es) 1997-07-18 1998-07-17 COMPOSICIoN FARMACÉUTICA DE 5-(4- (2-(N-METIL-N-(2-PIRIDIL) AMINO)ETOXI)BENCIL)TIAZOLIDIN-2-4-DIONA Y UN SECRETAGOGO DE INSULINA Y USO DE LA MISMA PARA PREPARACIoN DE MEDICAMENTOS
ARP990102953A AR019331A2 (es) 1997-07-18 1999-06-18 Composicion farmaceutica que contiene un sensibilizador a insulina y un secretagogo de insulina.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP980103516A AR016768A1 (es) 1997-07-18 1998-07-17 COMPOSICIoN FARMACÉUTICA DE 5-(4- (2-(N-METIL-N-(2-PIRIDIL) AMINO)ETOXI)BENCIL)TIAZOLIDIN-2-4-DIONA Y UN SECRETAGOGO DE INSULINA Y USO DE LA MISMA PARA PREPARACIoN DE MEDICAMENTOS

Country Status (40)

Country Link
EP (1) EP0998291B2 (es)
JP (2) JP2001510158A (es)
KR (1) KR100680667B1 (es)
CN (1) CN1264302A (es)
AP (1) AP1318A (es)
AR (2) AR016768A1 (es)
AT (1) ATE366577T1 (es)
AU (1) AU743269B2 (es)
BG (1) BG64892B1 (es)
BR (1) BR9810904A (es)
CA (1) CA2297115C (es)
CO (1) CO4940422A1 (es)
CY (1) CY1107745T1 (es)
CZ (1) CZ302668B6 (es)
DE (1) DE69838066T3 (es)
DK (1) DK0998291T4 (es)
DZ (1) DZ2564A1 (es)
EA (1) EA003303B1 (es)
ES (1) ES2290989T5 (es)
GB (1) GB9715306D0 (es)
HU (1) HU229119B1 (es)
ID (1) ID24198A (es)
IL (1) IL134045A0 (es)
IN (1) IN189035B (es)
MA (1) MA26522A1 (es)
MY (1) MY138246A (es)
NO (1) NO326356B1 (es)
NZ (3) NZ515555A (es)
OA (1) OA11632A (es)
PE (1) PE99799A1 (es)
PL (2) PL338127A1 (es)
PT (1) PT998291E (es)
SI (1) SI0998291T2 (es)
SK (2) SK287823B6 (es)
TR (1) TR200000135T2 (es)
TW (1) TW586926B (es)
UA (1) UA70302C2 (es)
UY (1) UY25103A1 (es)
WO (1) WO1999003476A1 (es)
ZA (1) ZA986365B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
EP1897547A1 (en) * 1999-07-13 2008-03-12 Medicure Inc. Use of pyridoxal phosphate derivatives for the treatment of diabetes and related complications
EP1832291A3 (en) * 1999-07-13 2009-11-04 Medicure Inc. use of pyridoxal phosphate for the treatment of diabetes and related complications
US6586438B2 (en) 1999-11-03 2003-07-01 Bristol-Myers Squibb Co. Antidiabetic formulation and method
US20010036479A1 (en) 2000-01-14 2001-11-01 Gillian Cave Glyburide composition
US7964216B2 (en) 2001-01-12 2011-06-21 Sun Pharma Advanced Research Company Limited Spaced drug delivery system
TWI339586B (en) 2003-10-31 2011-04-01 Takeda Chemical Industries Ltd Solid preparation comprising pioglitazone or salt thereof,glimpiride and polyoxyethylene sorbitan fatty acid ester
JP2008019169A (ja) * 2004-10-25 2008-01-31 Osaka Univ 新規ｐｐａｒ調節剤およびそのスクリーニング方法
WO2007072992A2 (en) 2005-12-22 2007-06-28 Takeda Pharmaceutical Company Limited Solid preparation containing an insulin sensitizer

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS5697277A (en) * 1980-01-07 1981-08-05 Takeda Chem Ind Ltd Thiazolidine derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
US4582839A (en) * 1984-03-21 1986-04-15 Takeda Chemical Industries, Ltd. 2,4-thiazolidinediones
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US4812570A (en) * 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
ATE186724T1 (de) * 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
US4791125A (en) * 1987-12-02 1988-12-13 Pfizer Inc. Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents
WO1989008651A1 (en) * 1988-03-08 1989-09-21 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
FI904414A7 (fi) * 1988-03-08 1990-09-07 Pfizer Tiatsolidiinidioni-hypoglykeemisesti vaikuttavat aineet
WO1991007107A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Oxazolidinedione hypoglycemic agents
JPH04210683A (ja) * 1990-12-06 1992-07-31 Terumo Corp チアゾリジン−２，４−ジオン誘導体およびこれを含有する糖尿病合併症治療薬
US5183823A (en) * 1991-04-11 1993-02-02 Takeda Chemical Industries, Ltd. Pyridine n-oxide compounds which are useful as hypoglycemic and hypolipidemic agents
ATE139130T1 (de) * 1991-08-16 1996-06-15 Sandoz Ag Inhalator zur verabreichung von pulverförmigen substanzen
JPH06510286A (ja) * 1991-08-26 1994-11-17 ファルマシア・アンド・アップジョン・カンパニー ３−グアニジノプロピオン酸およびピオグリタゾン、グリベンクラミドまたはグリメピリドを含有する医薬組成物
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US5859037A (en) * 1997-02-19 1999-01-12 Warner-Lambert Company Sulfonylurea-glitazone combinations for diabetes

Also Published As

Publication number Publication date
CN1264302A (zh) 2000-08-23
SK287823B6 (sk) 2011-11-04
MY138246A (en) 2009-05-29
NZ501256A (en) 2002-09-27
BR9810904A (pt) 2000-09-26
SI0998291T1 (sl) 2007-12-31
HU229119B1 (en) 2013-08-28
DK0998291T4 (da) 2011-09-26
TR200000135T2 (tr) 2000-05-22
SK602000A3 (en) 2000-07-11
ZA986365B (en) 2000-01-17
EA200000141A1 (ru) 2000-08-28
WO1999003476A1 (en) 1999-01-28
UA70302C2 (uk) 2004-10-15
GB9715306D0 (en) 1997-09-24
DK0998291T3 (da) 2007-11-05
MA26522A1 (fr) 2004-12-20
TW586926B (en) 2004-05-11
EP0998291A1 (en) 2000-05-10
NO20000229D0 (no) 2000-01-17
DZ2564A1 (fr) 2003-02-15
DE69838066T3 (de) 2012-03-29
PL338127A1 (en) 2000-09-25
AP2000001734A0 (en) 2000-03-31
NO326356B1 (no) 2008-11-17
EP0998291B1 (en) 2007-07-11
ES2290989T3 (es) 2008-02-16
ATE366577T1 (de) 2007-08-15
PT998291E (pt) 2007-10-11
AU8448798A (en) 1999-02-10
HUP0003634A2 (hu) 2001-07-30
AP1318A (en) 2004-10-22
DE69838066T2 (de) 2008-03-20
EA003303B1 (ru) 2003-04-24
NO20000229L (no) 2000-01-17
PE99799A1 (es) 1999-12-22
AR016768A1 (es) 2001-08-01
ID24198A (id) 2000-07-13
AU743269B2 (en) 2002-01-24
HK1029272A1 (en) 2001-03-30
SI0998291T2 (sl) 2011-10-28
BG64892B1 (bg) 2006-08-31
IL134045A0 (en) 2001-04-30
HUP0003634A3 (en) 2003-04-28
OA11632A (en) 2004-11-22
SK288053B6 (sk) 2013-03-01
BG104139A (en) 2000-11-30
UY25103A1 (es) 2000-12-29
NZ520652A (en) 2004-06-25
KR20010021948A (ko) 2001-03-15
KR100680667B1 (ko) 2007-02-09
CO4940422A1 (es) 2000-07-24
PL199125B1 (pl) 2008-08-29
EP0998291B2 (en) 2011-07-06
CA2297115A1 (en) 1999-01-28
CZ302668B6 (cs) 2011-08-24
JP2005247865A (ja) 2005-09-15
JP2001510158A (ja) 2001-07-31
CA2297115C (en) 2010-02-23
DE69838066D1 (de) 2007-08-23
ES2290989T5 (es) 2011-11-11
NZ515555A (en) 2002-09-27
IN189035B (es) 2002-12-07
CY1107745T1 (el) 2013-04-18
CZ2000173A3 (en) 2001-05-16

Similar Documents

Publication Publication Date Title
MY124695A (en) Novel composition and use.
ES2163511T3 (es) Preparacion farmaceutica conteniendo glucagon.
MX9700082A (es) Composicion que consiste de morfina, polipirrolidona y oxido de polialquileno.
CY1107909T1 (el) Πολυστρωματικο δισκιο περιεχον ροσιγλιταζονη
PL341054A1 (en) Novel suppositiories containing an active compound being unstable in acid environments
EE200000320A (et) Uudsed ühendid
SE9704544D0 (sv) Novel compounds
NL194239B (nl) Dialkoxyfosfinolmethylbenzamideverbindingen en farmaceutische preparaten, die deze bevatten.
DE69726015D1 (de) Pharmazeutische zusammensetzung enthaltend koenzym q-10
LU91138I2 (fr) Glulisine d'insuline et ses dérivés pharmaceutiquement acceptables.
MY118392A (en) Variable day start tablet dispenser
DE69814091D1 (de) Voriconazol-enthaltende pharmazeutische zubereitungen
MX9602683A (es) Compuestos de 6-dimetilaminometil-1-fenil-ciclohexano como substancias farmaceuticamente activas.
ATE154237T1 (de) Inhalationspulver enthaltend antistatisches hilfsmittel
ZA962536B (en) Pharmaceutical composition for transdermal administration.
DE59712694D1 (de) Stabilisiertes arzneimittel enthaltend cysteinylderivate
FI932553A7 (fi) Uusia farmaseuttisia formulaatioita, jotka sisältävät farmakologisesti aktiivista ionisoitavaa ainetta, sekä menetelmä niiden valmistamiseksi
MY118828A (en) Substituted amino compounds and their use as substances having an analgesic effect
DE60019334D1 (de) Antivirale arznei
ATE240720T1 (de) Paracetamol enthaltende schlickbare tablette
MX9800408A (es) Sales de derivados de amidina y de inhibidor de ciclooxigenasa, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
FI954986L (fi) Uudet, suun kautta annettavat, syklosporiinia sisältävät farmaseuttiset valmisteet
IL148003A0 (en) Floating pharmaceutical composition comprising an active phase and a non-active phase
NO307048B1 (no) N-metyl-N-[(1S)-1-fenyl-2-((3S)-3-hydroksypyrrolidin-1-yl)- etyl]-2,2-difenylacetamidhydroklorid, legemiddel som inneholder forbindelsen, anvendelse av legemidlet til fremstilling av legemiddelpreparater, farmasøytiske preparater som inneholder l
MX9708394A (es) Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.

Legal Events

Date Code Title Description
FB Suspension of granting procedure